Sanochemia Pharmazeutika, Vienna, acquires a majority share in AlcaSynn Pharmaceuticals, for EUR 12 milion.
Interim manager of AlcaSynn from 2003 to 2004 until the incorporation as a GmbH (Ltd.).
CEO of AlcaSynn since incorporation in 2004.
Setup of organization.
Acquisition of grants and soft Loans > € 1 million.
Acquisition of corporate venture capital > € 10 million.
Trade Sale to Sanochemia Pharmazeutika, Vienna, in 2006.
Pre-money valuation of € 8 million.
Find the official press release here